HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Peters Selected Research

CI 1044

7/2011Effects of modulating in vivo nitric oxide production on the incidence and severity of PDE4 inhibitor-induced vascular injury in Sprague-Dawley rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Peters Research Topics

Disease

3Neoplasms (Cancer)
04/2011 - 02/2006
2Pain (Aches)
01/2019 - 06/2011
2Atherosclerotic Plaque (Atheroma)
04/2011 - 06/2009
2Atherosclerosis
04/2011 - 06/2009
2Rupture
06/2009 - 05/2004
1COVID-19
01/2022
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2020
1Infections
11/2019
1Neuralgia (Stump Neuralgia)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Polyneuropathies (Polyneuropathy)
01/2019
1Hemimegalencephaly
01/2017
1Hydrocephalus (Hydrocephaly)
01/2017
1Seizures (Absence Seizure)
01/2017
1Pre-Eclampsia (Preeclampsia)
01/2014
1Hyperoxia
02/2013
1Vascular System Injuries
07/2011
1Anastomotic Leak
12/2010
1Pathologic Constriction (Stenosis)
12/2010
1Wounds and Injuries (Trauma)
02/2006
1Carcinoma (Carcinomatosis)
10/2005
1Ovarian Neoplasms (Ovarian Cancer)
10/2005
1Ruptured Aneurysm
06/2004
1Intracranial Aneurysm (Cerebral Aneurysm)
05/2004
1Aneurysm (Aneurysms)
05/2004
1Anemia
08/2003

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
01/2017 - 07/2011
2Peptides (Polypeptides)IBA
04/2011 - 02/2006
2Fluorescein (Funduscein)FDA LinkGeneric
04/2011 - 02/2006
2Apolipoproteins E (ApoE)IBA
04/2011 - 06/2009
2Blood Proteins (Serum Proteins)IBA
06/2009 - 02/2006
2Biomarkers (Surrogate Marker)IBA
10/2005 - 05/2004
1ChAdOx1 nCoV-19IBA
01/2022
1VaccinesIBA
01/2022
1OxazolesIBA
01/2020
1UtrophinIBA
01/2020
1EstersIBA
01/2020
1Histamine Receptors (Histamine Receptor)IBA
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
01/2019
1Potassium Channels (Potassium Channel)IBA
01/2019
1Analgesics (Analgesic Drugs)IBA
01/2019
1Loxapine (Loxitane)FDA LinkGeneric
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Messenger RNA (mRNA)IBA
01/2014
1Oxygen (Dioxygen)IBA
02/2013
1Phosphodiesterase 4 InhibitorsIBA
07/2011
1CI 1044IBA
07/2011
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
07/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2011
1ApolipoproteinsIBA
04/2011
1Prostate-Specific Antigen (Semenogelase)IBA
12/2010
1Arginine (L-Arginine)FDA Link
06/2009
1Lysine (L-Lysine)FDA Link
06/2009
1Phenobarbital (Luminal)FDA Link
06/2009
1Cysteine (L-Cysteine)FDA Link
06/2009
1Glutamic Acid (Glutamate)FDA Link
06/2009
1Alanine (L-Alanine)FDA Link
06/2009
1MicellesIBA
06/2009
1Fibronectins (Fibronectin)IBA
02/2006
1Fibrinogen (Factor I)FDA Link
02/2006
1estropipate (Ogen)FDA LinkGeneric
02/2006
1FibrinIBA
02/2006
1Carboplatin (JM8)FDA LinkGeneric
10/2005
1xylometazoline (stas)IBA
06/2004
1Epoprostenol (Prostacyclin)FDA LinkGeneric
06/2004
1DNA (Deoxyribonucleic Acid)IBA
05/2004
1CreatinineIBA
08/2003

Therapy/Procedure

2Therapeutics
01/2019 - 06/2009
1Patient Readmission
11/2019
1Drug Therapy (Chemotherapy)
01/2019
1Ventriculoperitoneal Shunt
01/2017
1Spinal Manipulation
06/2011
1Prostatectomy (Retropubic Prostatectomy)
12/2010
1Operative Time
12/2010